Conexeu ChatGPT ad — Potential GLP-1 Aftermarket Stock: CNXU in Diabetes Management

Potential GLP-1 Aftermarket Stock: CNXU

CNXU is a patented, clinical-stage biotech built for the post-GLP-1 aesthetics market.

The real user prompts we captured this ad appearing on inside ChatGPT.

  • mounjaro vs zepbound are they the same drug or actually different

Why does this ad win these prompts?

The prompts are the clue. The answer is the audience it is really aimed at, and the context hint quietly placing it here.

Seen 1× across our captures

We capture sponsored ads inside ChatGPT by probing it with realistic consumer prompts and recording the creative + the triggering prompt. Explore the full ad library.

Something missing, or want to work together?

Questions about the data, a brand you expected to see, partnerships, or access to the intelligence layer. We read every message.

Contact us →